Anika Therapeutics Inc. (NASDAQ: ANIK) stock closed at 21.74 per share at the end of the most recent trading day (a -5.48% change compared to the prior day closing price) with a volume of 122.00K shares and market capitalization of 317.38M. Is a component of indices and it is traded on NASDAQ exchange. The company belongs in the Biotechnology industry, Healthcare sector and employs 154 people. Anika Therapeutics Inc. CEO is Cheryl R. Blanchard.

The one-year performance of Anika Therapeutics Inc. stock is -43.11%, while year-to-date (YTD) performance is -39.32%. ANIK stock has a five-year performance of -57.97%. Its 52-week range is between 19.9508 and 45.81, which gives ANIK stock a 52-week price range ratio of 6.92%

Anika Therapeutics Inc. currently has a PE ratio of -210.70, a price-to-book (PB) ratio of 1.18, a price-to-sale (PS) ratio of 2.88, a price to cashflow ratio of 37.90, a PEG ratio of 2.32, a ROA of -0.48%, a ROC of -0.54% and a ROE of -0.60%. The company’s profit margin is -6.78%, its EBITDA margin is -2.70%, and its revenue ttm is $112.05 Million , which makes it $7.70 revenue per share.

Of the last four earnings reports from Anika Therapeutics Inc., there were 2 positive earnings surprise and 1 negative earnings surprise. The company has EPS estimate of $-0.19 for the next earnings report. Anika Therapeutics Inc.’s next earnings report date is -.

The consensus rating of Wall Street analysts for Anika Therapeutics Inc. is Hold (3), with a target price of $29, which is +33.39% compared to the current price. The earnings rating for Anika Therapeutics Inc. stock is Strong Sell (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).

Anika Therapeutics Inc. has a dividend yield of -% with a dividend per share of $- and a payout ratio of -%.

Anika Therapeutics Inc. has a Sell technical analysis rating based on Technical Indicators (ADX : 11.38, ATR14 : 1.01, CCI20 : -133.31, Chaikin Money Flow : -0.23, MACD : 0.07, Money Flow Index : 40.27, ROC : -5.93, RSI : 39.97, STOCH (14,3) : 3.08, STOCH RSI : 0.00, UO : 36.86, Williams %R : -96.92), Simple Moving Averages and Exponential Moving Averages.

Aggregated Insider Trades of Anika Therapeutics Inc. in the last 12-months were: Cheryl R. Blanchard (Buy at a value of $207 143), Cheryl R. Blanchard (Option Excercise at a value of $0), David Colleran (Buy at a value of $72 033), David Colleran (Option Excercise at a value of $0), Jeffery Scott Thompson (Buy at a value of $49 318), Michael L. Levitz (Buy at a value of $129 715), Michael L. Levitz (Option Excercise at a value of $0), Thomas Finnerty (Option Excercise at a value of $0)